CarolaAnne SylviaArndtMD

Pediatric Hematology & Oncology • Rochester, MN

Pediatric Coagulation Disorder Hematology, Pediatric Sarcoma Oncology

Professor of Pediatrics

Join to view full profile

Dr. Arndt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Arndt's full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1984 - 1987
Naval Medical Center (San Diego)Residency, Pediatrics, 1978 - 1981
Boston University School of MedicineClass of 1978
Boston UniversityB.A., 1978

Certifications & Licensure

MN State Medical License 1990 - 2025
PA State Medical License 1982 - 1988
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
First Place Award, OKAP examination Cleveland Clinic Cole Eye Institute, 2008
AOA Medical Honor Society University of Michigan Medical School, 2005
Merrill Presidential Scholar Cornell University, 2002
Ertel-Diamant Premedical Award Cornell University, 2002
Paul Schreurs Research Award, Honorable Mention Cornell University, 2002
A.L. Morris Diligence Award Cornell University, 2001
Big Red Wall of Power Cornell University, 2001
Secret Honor Society of the Quill and Dagger – 40 Cornell University seniors selected for qualities of leadership, character, and service 2001
Dean’s List every semester Cornell University, 1998
400 Club, 3 time member Cornell University, 1998
Career Development Award American Cancer Society, 1991
Young Investigator in Training Award American Society of Clinical Oncology, 1987
Phi Beta Kappa Honor Society
Citation for Scholastic Achievement American Medical Women's Association
Alpha Omega Alpha Alpha Omega Alpha Honor Medical Society
Join now to see all

Clinical Trials

Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma Start of enrollment: 2002 Sep 01
Completed
Phase 3
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma Start of enrollment: 2004 Jul 01
Completed
Phase 2
High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma Start of enrollment: 2006 Jul 01
Completed
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Patients With Sarcoma Start of enrollment: 1991 Oct 01
Completed
Early Phase 1
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
Recruiting
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Start of enrollment: 2012 Feb 21
Active, not recruiting
Phase 3
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma Start of enrollment: 2012 Aug 01
Completed
Phase 2
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
Completed
Phase 2
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
Active, not recruiting
Phase 2, Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

Late Events Occurring After 5 Years in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Sara Kreimer, Wei Xue, Amira Qumseya, Timothy B Lautz, Archana Shenoy
Pediatric Blood & Cancer. 2025-01-01
1 citations
Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Rochelle Bagatell, Julie R Park, Sahaja Acharya, Jennifer Aldrink, Jenna Allison
Journal of the National Comprehensive Cancer Network. 2024-08-01
The Problematic PET: Using CT Albumin Tracer to Resect Suspicious Lymph Nodes Found on PET Scan in Pediatric Oncology Patients.
Taleen A MacArthur, Michael D Traynor Jr, Denise B Klinkner, Stephanie F Polites, Carola Arndt
Journal of Pediatric Surgery. 2023-08-01

Journal Articles

Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the children's oncology group soft tis...
Rodeberg DA, Wharam MD, Lyden ER, Stoner JA, Brown K, Wolden SL, Paidas CN, Donaldson SS, Hawkins DS, Spunt SL, Arndt CA, Int J Cancer, 1/1/2015
Stereotactic body radiotherapy for metastatic and recurrent ewing sarcoma and osteosarcoma
Brown LC, Lester RA, Grams MP, Haddock MG, Olivier KR, Arndt CA, Rose PS, Laack NN, Sarcoma, 1/1/2014
Caspofungin Versus Liposomal Amphotericin B: Are They Really Comparable?
Walsh TJ, Maertens JA, Madero L, Reilly AF, Lehrnbecher T, Groll AH, Jafri HS, Green M, Nania JJ, Bourque MR, Ann Wise B, Strohmaier KM, Taylor AF, Kartsonis NA, Chow ..., Pediatr Infect Dis J, 1/1/2010
Neurofibromatosis in children with rhabdomyosarcoma: A report from the intergroup Rhabdomyosarcoma Study IV
Sung L, Anderson JR, Arndt C, Raney B, Meyer WH, Pappo AS, J Pediatr, 1/1/2004
Musculoskeletal tumors of childhood - reply
Arndt CAS, Crist WM, N Engl J Med, 1/25/1999
Liposomal amphotericin B for fever and neutropenia - reply
Walsh TJ, Arndt C, Dismukes W, N Engl J Med, 1/7/1999
Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas
Adde M, Shad A, Venzon D, Arndt C, Gootenberg J, Neely J, Nieder M, Owen W, Seibel N, Wilson W, Horak ID, Magrath I, Semin Oncol, 1/1/1998
Inguinal lipoblastomatosis in a male infant
Russell ST, Gettman MT, Arndt CA, Nascimento AG, Kramer SA, J Urol, 1/1/1998
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen
Magrath I, Adde M, Shad A, Venzon D, Seibel N, Gootenberg J, Neely J, Arndt C, Nieder M, Jaffe E, Wittes RA, Horak ID, J Clin Oncol, 1/1/1996
Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine
Weintraub M, Adde MA, Venzon DJ, Shad AT, Horak ID, Neely JE, Seibel NL, Gootenberg J, Arndt C, Nieder ML, Magrath IT, J Clin Oncol, 1/1/1996
Osteosarcoma in adolescents and young adults: New developments and controversies
Miser JS, Pritchard DJ, Rock MG, Shives TC, Gilchrist GS, Smithson WA, Arndt CA, Edmonson JH, Schaid DJ, The Mayo Clinic studies, Cancer Treat Res, 1/1/1993
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule
Adamson PC, Balis FM, Miser JS, Arndt C, Wells RJ, Gillespie A, Aronson L, Penta JS, Clendeninn NJ, Poplack DG, CA Res, 1/1/1992
Use of a continuous intravenous morphine infusion for pain control in an infant with terminal malignancy
Dothage JA, Arndt C, Miser AW, J Assn Pediatr Nurses, 1/1/1986
Join now to see all

Books/Book Chapters

Nelson textbook of pediatrics
Chapter: Malignant tumors of bone
Page 1763 - 1766Arndt CASEditors: Kliegman RM; et al.Saunders Elsevier, Philadelphia, PAEdition 19th,2011
Nelson textbook of pediatrics
Chapter: Benign tumors and tumor-like processes of bone
Page 1766 - 1768Arndt CASEditors: Kliegman RM; et al.Saunders Elsevier, Philadelphia, PAEdition 19th,2011
Current pediatric therapy
Chapter: Neruoblastoma
Page 1185 - 1187Arndt CASEditors: Burg FD, et al.Saunders Elsevier, Philadelphia, PA2006
National Institute NIH Pub
Chapter: Cancer Epidemiology in Older Adolescents, Young Adults 15 to 29 Years of Age, including SEER Incidence and Survival: 1975-2000
Page 97 - 110Mascarenhas L, Siegel S, Spector L, Arndt C, Femino D, Malogolowkin MEditors: Bleyer A, O’Leary M, Barr R, Ries LAG.Bethesda, MD2006
Gellis and Kagan's Current Pediatric Therapy
Chapter: Neuroblastoma
Page 1005 - 1006Arndt CAEditors: Behrman RE, et al.W. B. Saunders Company, Philadelphia, PA2002
Oxford Textbook of Orthopaedics and Trauma
Chapter: Metastatic neuroblastoma
Page 358 - 361Papagelopoulos PJ, Galanis E, Arndt CAS, Sim FEditors: C. Bulstrode, et al.Oxford University Press2002
Oxford textbook of orthopedics and trauma
Chapter: Rhabdomyosarcoma
Page 323 - 328Arndt CASEditors: Bulstrode C, et al.Oxford: Oxford University Press2002
Oxford textbook of orthopedics and trauma
Chapter: Metastatic neuroblastoma
Page 358 - 361Papagelopoulos PJ, Galanis EC, Arndt CAS, Sim FHEditors: Bulstrode C, et al.Oxford: Oxford University Press2002
Oxford textbook of orthopedics and trauma
Chapter: Wilms' tumor
Page 361 - 363Papagelopoulos PJ, Galanis EC, Arndt CAS, Sim FHEditors: Bulstrode C, et al.Oxford: Oxford University Press2002
Nelson Textbook of Pediatrics
Chapter: The leukemias: acute myeloid leukemia
Page 1546 - 1547Arndt CAS, Anderson PMEditors: Behrman RE, et al.W. B. Saunders Company, Philadelphia, PAEdition 16th,2000
Nelson Textbook of Pediatrics
Chapter: Soft tissue sarcomas
Page 1556 - 1558Crist WM, Arndt CASEditors: Behrman RE, et al.W. B. Saunders Company, Philadelphia, PAEdition 16th,2000
Nelson Textbook of Pediatrics
Chapter: Neoplasms of bone
Page 1558 - 1561Arndt CASEditors: Behrman RE, et al.W. B. Saunders Company, Philadelphia, PA2000
Nelson Textbook of Pediatrics
Chapter: Benign tumors
Page 1567 - 1570Shaughnessy WJ, Arndt CASEditors: Behrman RE, et al.W. B. Saunders Company, Philadelphia, PAEdition 16th,2000
Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies
Chapter: The Mayo Clinic studies
Page 333 - 338Miser JS, Pritchard DJ, Rock MG, Shives TC, Gilchrist GS, Smithson WA, Arndt CAS, Edmonson JH, Schaid DJEditors: Humphrey GB, et al.Kluwer Academic Publishers, Boston, MA1993
Conn's Current Therapy
Chapter: Acute leukemia in childhood
Page 357 - 363Arndt CAS, Gilchrist GSEditors: Rakel RE.W. B. Saunders Co, Philadelphia, PA1991
Nelson textbook of pediatrics
Chapter: Benign Tumors and Tumor Like Processes
Arndt CASEditors: Behrman RE, Kliegman RM, Jenson HB.Edition 17th,
Join now to see all

Abstracts/Posters

Severe agammaglobinemia with profound neutropenia presenting with pseudomonas bacteremia and pneumonia with balanced 5;17 chromosomal translocation
Abdul T, Boyce TG, Arndt C, Babovic-Vuksanovic D, Joshi AY, J Clin Immunol, 1/1/2015
Assessment of nutritional status in newly diagnosed pediatric patients: Mayo Clinic experience
Bidadi B, Al Nofal A, Marri P, Lamprecht M, Arndt C, Pediatr Blood Cancer, 1/1/2014
Self-reported functional outcomes and quality of life assessments in long-term survivors of Ewing sarcoma
Stish BJ, Laack NN, Ahmed SK, Rose PS, Arndt CA, Int J Radiat Oncol Biol Phys, 1/1/2014
A rare case of siblings with metastatic Ewing sarcoma
Bidadi B, Rodriguez V, Rose P, Arndt C, NageswaraRao A, Pediatr Blood Cancer, 1/1/2014
Stereotactic body radiation therapy (sbrt) for pediatric bone tumors
Brown LC, Lester RA, Haddock MG, Sarkaria JN, Olivier KR, Arndt CAS, Laack NN, Int J Radiat Oncol Biol Phys, 1/1/2013
Interim report of a randomized, open-label, multicenter study to evaluate the safety and efficacy of decitabine as an epigenetic priming agent when combined with induc...
Gore L, Macy ME, Mechinaud F, Narendran A, Alvaro F, Arndt CAS, Barnette P, Boklan J, Cooper T, Martin L, Tcheng W, Tarassoff P, Jones MM, Meshinchi S, Arceci RJ, Blood, 1/16/2012
Interim report of a randomized, open-label, multicenter study to evaluate the safety and efficacy of decitabine as an epigenetic priming agent when combined with induc...
Arndt C, 54th Annual Meeting of the American Society of Hematology, Atlanta, GA, 1/1/2012
Clinical outcomes in adult and pediatric Ewing sarcoma: a single institution comparative study
Ahmed S, Robinson SI, Okuno SH, Rose PS, Arndt CA, Laack NN, Int J Radiat Oncol Biol Phy, 1/1/2012
Three fold variation in dosing chemotherapy agents in infants according to calculation method
Altaf S, Lyden E, Arndt C, Pediatr Blood Cancer, 1/1/2012
Risk of toxicity, relapse and mortality in overweight and underweight children with osteosarcoma
Altaf S, Enders F, Jeavons E, Barkauskas D, Meyers P, Arndt C, Pediatr Blood Cancer, 1/1/2012
Is there a difference by age in toxicity in patients treated with vincristine and cyclophosphamide for intermediate risk rhabdomyosarcoma?
Altaf S, Enders F, Jeavons E, Lyden E, Hawkins D, Arndt C, Pediatr Blood Cancer, 1/1/2012
Inhaled GM-CSF for first pulmonary recurrence of osteosarcoma: a report from the Children's Oncology Group
Arndt C, Koshkina N, Inwards C, Hawkins D, Krailo M, Villaluna D, Anderson P, Goorin A, Blakely M, Bernstein M, Bell S, Ray K, Grendahl D, Marina N, Kleinerman E, American Society of Pediatric Oncology, Quebec, Canada, 1/1/2010
Are weight/BMI at diagnosis or weight change on therapy predictive of toxicity in intermediate risk rhabdomyosarcoma? Children's oncology group report
Burke M, Lyden E, Meza J, Ladas E, Arndt C, Pediatr Blood Cancer, 1/1/2010
Inhaled GM-CSF for first pulmonary recurrence of osteosarcoma: a report from the children's oncology group
Arndt C, Koshkina N, Inwards C, Hawkins D, Krailo M, Villaluna D, Anderson P, Goorin A, Blakely M, Bernstein M, Bell S, Ray K, Grendahl D, Marina N, Kleinerman E, Pediatr Blood Cancer, 1/1/2010
Second Look Operation with Subsequent Modification of Radiotherapy Dose for Intermediate Risk Rhabdomyosarcoma (RMS): A Report from the Children's Oncology Group (COG)
Rodeberg D, Wharam M, Lyden E, Stoner J, Brown K, Wolden S, Paidas C, Donaldson S, Hawkins D, Spunt S, Arndt C, RMS, 1/1/2010
Randomized phase III trial comparing vincristine, actinomycin, cyclophosphamide (VAC) with VAC/V topotecan/cyclophosphamide(TC) for intermediate risk rhabdomyosarcoma ...
Arndt CAS, Am Soc Clinical Oncol, 1/1/2007
The IL-2 induced de-ubiquitinating enzyme, DUB-2, is a nuclear cytoplasmic shuttle which requires catalytic activity for nuclear localization
Galardy PJ, D'Andrea AD, Ploegh HL, Arndt CAS, Blood, 1/1/2006
Significance of persistent rhabdomyoblasts in bladder prostate rhabdomyosarcoma: results from the fourth intergroup rhabodomyosarcoma study
Arndt C, Hammond S, Rodeberg D, Qualman S, Sarcoma, 1/1/2005
Fas expression in osteosarcoma lung metastasis is correlated with chemotherapy prior to surgery
Gordon NB, Arndt CA, Hawkins DS, Doherty DK, Inwards CY, Munsell M, Koshkina N, Kleinerman ES, AACR, 1/1/2005
Use of Infliximab/Daclizumab combination for the treatment of acute and chronic graft versus host disease of the liver and gut
Rodriguez V, Trotz B, Anderson PM, Arndt CAS, Allen J, Khan SP, Biol Blood Marrow Transplant, 1/1/2005
Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ ifosfamide with the fourth intergroup rhabdomyosarcoma st...
Arndt C, Anderson J, Meyer W, Hawkins D, Sencer S, Neglia J, Sarcoma, 1/1/2005
Fas expression in osteosarcoma lung metastasis is correlated with chemotherapy prior to surgery
Gordon NB, Arndt CA, Hawkins DS, Doherty DK, Inwards CY, Munsell MF, Koshkina NV, Kleinerman ES, Pediatr Blood Cancer, 1/1/2005
Does early myeloid recovery predict superior survival in children and young adults undergoing hematopoietic stem cell transplantation?
Imran H, Khan SP, Arndt CAS, Rodriguez V, Allen JA, Trotz BA, Blood, 1/1/2005
Outcome and local control (LC) for bladder prostate rhabdomyosarcoma (BP RMS) on IRS IV
Arndt CA, Rodeberg DA, Ullrich F, Donaldson SS, Anderson JR, Raney RB, Breitfeld PP, et al, Pediatr Res, 1/1/2003
Outcome and local control (LC) for bladder prostate rhabdomyosarcoma (BP RMS) on IRS IV
Arndt CA, Rodeberg DA, Ullrich F, Donaldson SS, Anderson JR, Raney RB, Breitfeld PP, J Pediatr Hematol Oncol, 1/1/2003
Join now to see all

Lectures

Rhabdomyosarcoma, Two sides of the Atlantic
Antalya, Turkey - 1/1/2011
High Risk Rhabdomyosarcoma, Challenges, Controversies, Approaches
Antalya, Turkey - 1/1/2011
Controversies in Management of Bladder Prostate Rhabdomyoscarcoma
Antalya, Turkey - 1/1/2011
Malignant Bone Tumors
Izmir, Turkey - 1/1/2011
Second Look Operation with Subsequent Modification of Radiotherapy Dose for Intermediate Risk Rhabdomyosarcoma (RMS): A Report from the Children's Oncology Group (COG)
Chicago, IL - 1/1/2010
Inhaled GM CSF for first pulmonary recurrence of osteosarcoma: immunologic and surgical findings: report from the Children’s Oncology Group
Paris, France - 1/1/2010
"Blood is a Very Special Juice" or "Evaluation of the Anemic Child"
San Antonio, TX - 1/1/2009
Subgroup Outcome for Intermediate Risk Rhabdomyosarcoma (RMS)on VAC vs VAC/VTC (D9803)
Berlin, Germany - 1/1/2008
Practicing pediatrics at Mayo Clinic
Akita, Japan - 1/1/2008
Mayo Clinic Model of Care
Akita, Japan - 1/1/2008
Update on bone tumors
Akita, Japan - 1/1/2008
D9803 Preliminary Results: VAC vs VAC/VTC for Intermediate Risk Rhabdomyosarcoma
Chicago, IL - 1/1/2007
Arndt C. Role of Doxorubicin in Rhabdomyosarcoma: Is the Answer Knowable?
Chicago, IL - 1/1/2006
Fas Expression in Osteosarcoma Lung Metastasis is Correlated with 2005 Chemotherapy Prior to Surgery
Anaheim, CA - 1/1/2005
COX-2 influences vascular regulation and correlates with clinical outcome in patients with relapsed pulmonary osteosarcoma
Bergamo, Italy - 1/1/2005
Comparison of Results of IRS IV with Alternating Vincristine, Doxorubicin, Cyclophosphamide and Etoposide/Ifosfamide for Intermediate Risk RMS
Stuttgart, Germany - 1/1/2005
Significance of Persistence of Rhabdomyoblasts in Bladder Prostate Rhabdomyosarcoma
Stuttgart, Germany - 1/1/2005
Chemotherapy of Osteosarcoma
Madrid, Spain - 1/1/2005
Age is a Risk Factor for Hepatopathy on the Intermediate Risk RMS Trial of VAC vs VAC/VTC
Chicago, IL - 1/1/2003
Intraabdominal Desmoplastic Small Round Cell Tumors: A Diagnostic and Therapeutic Challenge
Chicago, IL - 1/1/2003
Local Therapy and Outcome for Bladder Prostate Rhabdomyosarcoma on IRS IV
Seattle, WA - 1/1/2003
Treatment of Osteosarcoma and Ewing's Sarcoma
Olympia, Greece - 1/1/2001
Non-metastatic Osteosarcoma, the Mayo Clinic Experience
Naples, Italy - 1/1/1999
Therapy of Osteosarcoma
Rio de Janeiro, Brazil - 1/1/1999
Progress in Biology and Therapy of Ewing's Family of Tumors
Rio de Janeiro, Brazil - 1/1/1999
Join now to see all